| Stage | MDT | % of rev | ITGR | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $9.8B | 100.00% | $450M | 100.00% | MDT ×21.70 |
| Gross profit | $6.3B | 64.99% | $102M | 22.59% | MDT +42.4pp |
| Operating income | $1.8B | 18.08% | $28M | 6.27% | MDT +11.8pp |
| Pre-tax income | $1.8B | 18.13% | $18M | 3.89% | MDT +14.2pp |
| Net income | $1.5B | 15.16% | $15M | 3.33% | MDT +11.8pp |
| Stage | MDT | ITGR | Gap · A − B |
|---|---|---|---|
| Revenue | $9.8B100.00% | $450M100.00% | MDT ×21.70 |
| Gross profit | 64.99%$6.3B | 22.59%$102M | MDT +42.4pp |
| Operating income | 18.08%$1.8B | 6.27%$28M | MDT +11.8pp |
| Pre-tax income | 18.13%$1.8B | 3.89%$18M | MDT +14.2pp |
| Net income |
| 15.16%$1.5B |
| 3.33%$15M |
| MDT +11.8pp |
MDT · OBIO 10-KMar 12 '26
“In addition, we concluded that Medtronic is a customer for a good or service that is a distinct unit of account, and therefore, the transact ions in the Medtronic Agreement, as amended pursuant to the Medtronic Agreement Amendment (the "Amended Medtronic Agreement"), should be accounted for under ASC 606.”
ITGR · OBIO 10-KMar 12 '26
“The Moderato system, comprised of the implantable pulse generator ("IPG") and programmer, was manufactured under an original equipment manufacturer contract by a division of Integer Holdings Corporation ("Integer"), a leading supplier of cardiac rhythm management device components.”